Walleye Trading’s Fulgent Genetics FLGT Stock Holding History

Walleye Trading’s Portfolio FLGT Stock Details FLGT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-4,604	Closed	-$90.3K	–	4240
2024 Q2	$90.3K	Buy	4,604 +1,244	+37%	+$26K	﹤0.01%	3408
2024 Q1	$72.9K	Sell	3,360 -5,238	-61%	-$130K	﹤0.01%	3897
2023 Q4	$249K	Buy	+8,598	New	+$230K	﹤0.01%	3635
2022 Q4	–	Sell	-1,092	Closed	-$42K	–	5093
2022 Q3	$42K	Buy	1,092 +369	+51%	+$18.5K	﹤0.01%	4286
2022 Q2	$39K	Buy	+723	New	+$39.7K	﹤0.01%	4399
2021 Q4	–	Sell	-2,674	Closed	-$235K	–	5505
2021 Q3	$241K	Buy	+2,674	New	+$243K	﹤0.01%	3673
2021 Q2	–	Sell	-3,658	Closed	-$292K	–	5275
2021 Q1	$353K	Sell	3,658 -1,813	-33%	-$187K	﹤0.01%	3058
2020 Q4	$285K	Buy	+5,471	New	+$229K	﹤0.01%	3188

Other funds holding FLGT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PWAM

Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Walleye Trading's FLGT Position: Q3 2024 in Review

Walleye Trading sold out of Fulgent Genetics (FLGT) in Q3 2024, closing a stake of 4,604 shares — an estimated $90.3K sold.

Walleye Trading first reported a position in FLGT in Q4 2020 and held it in 8 quarters. The position peaked at $353K in Q1 2021. 183 funds tracked by Wall St. Rank hold FLGT as of Q3 2024.

Walleye Trading reported no remaining Fulgent Genetics position as of Q3 2024 after selling out during the quarter.
Walleye Trading sold 4,604 Fulgent Genetics shares in Q3 2024, an estimated $90.3K.
Walleye Trading first reported a position in Fulgent Genetics in Q4 2020 and held it in 8 quarters.
Walleye Trading's Fulgent Genetics position peaked at $353K in Q1 2021.
183 funds tracked by Wall St. Rank held Fulgent Genetics as of Q3 2024.

Based on Walleye Trading's 13F filing for Q3 2024, filed 14 Nov 2024.